Register entry
Fukuzyu Pharmaceutical Co., Ltd.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- Japan
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Fukuzyu Pharmaceutical Co., Ltd. | 48, Hagihara, Toyama, Toyama 939 8261, Japan (JPN) | Active ingredient (API) manufacture | 3002807025692442510 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Pyrimethamine | powder | 68057-001BULK INGREDIENT |
Neighbours
Registered in the same town
4- Astellas Pharma US, Inc.Toyama, JPN
- KATAYAMA SEIYAKUSYO CO., LTD.TOYAMA, JPN
- Lead Chemical Co., Ltd.Toyama, JPN
- Kongo Chemical Co., Ltd.Toyama, JPN
Compare
Comparable companies in Japan
- Sakai Chemical Industry Co., Ltd.1 site · 20 NDC
- KYOWA HAKKO BIO CO., LTD.1 site · 14 NDC
- Kyowa Kirin Co., Ltd.1 site · 11 NDC
- Titan Kogyo , Ltd.1 site · 8 NDC
- Kyowa Pharma Chemical Co., Ltd.1 site · 6 NDC
- Alps Pharmaceutical Ind. Co., Ltd.1 site · 5 NDC
- Kongo Chemical Co., Ltd.1 site · 5 NDC
- Yuki Gosei Kogyo Co., Ltd.1 site · 5 NDC
- Juzen Chemical Corporation1 site · 4 NDC
- Asahi Kasei Finechem Co., Ltd.1 site · 3 NDC
Enquiry
Common questions
- Is Fukuzyu Pharmaceutical Co., Ltd. FDA approved?
- Fukuzyu Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Fukuzyu Pharmaceutical Co., Ltd.'s drugs manufactured?
- The FDA register lists Toyama. Registered operations: active ingredient (API) manufacture.
- What drugs does Fukuzyu Pharmaceutical Co., Ltd. make?
- 1 product is listed under Fukuzyu Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.